GB1298172A - A method of isolating and chemically purifying amphotericin b - Google Patents

A method of isolating and chemically purifying amphotericin b

Info

Publication number
GB1298172A
GB1298172A GB1390671A GB1390671A GB1298172A GB 1298172 A GB1298172 A GB 1298172A GB 1390671 A GB1390671 A GB 1390671A GB 1390671 A GB1390671 A GB 1390671A GB 1298172 A GB1298172 A GB 1298172A
Authority
GB
United Kingdom
Prior art keywords
volume
dimethylformamide
solution
amphotericin
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1390671A
Inventor
Valter Osvaldovich Kulbakh
Evgeny Davidovich Etingov
Vladimir Semenovich Nyn
Markabovich Malkov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LE NII ANTIBIOTIKOV
Original Assignee
LE NII ANTIBIOTIKOV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LE NII ANTIBIOTIKOV filed Critical LE NII ANTIBIOTIKOV
Priority to GB1390671A priority Critical patent/GB1298172A/en
Publication of GB1298172A publication Critical patent/GB1298172A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1298172 Amphotericin B purification LENINGRADSKY NAUCHNO - ISSLEDOVATELSKY INSTITUT ANTIBIOTIKOV 8 May 1971 13906/71 Heading C2A A method of purifying crude amphotericin B comprises dissolving the crude antibiotic in dimethylformamide, adding distilled water to the solution in amount equal to half the volume of dimethylformamide used, acidifying the resulting mixture to a pH of between 2 and 3À6, removing the precipitated impurities, adding to the filtrate a volume of water equal to the volume of dimethylformamide used, adjusting the pH of the solution to a pH of from 6À5 to 7À0 and recovering the precipitated product. Preferably, the solution of the crude antibiotic in dimethylformamide is prepared by mixing 1 part by weight of crude antibiotic with from 10 to 20 parts by volume of dimethylformamide, followed by acidifying the resulting mixture with hydrochloric acid to pH 7 to 7À5. Then the mixture is stirred for 1À5 to 2 hours until the heptaenes are completely dissolved. Distilled water is then poured slowly into the mixture with stirring, in an amount of half the volume of the dimethylformamide used. The pH of the resultant solution is brought to 2À0 to 3À6 and the resultant precipitate, which consists mainly of antibiotically inactive heptaenes, is filtered off. Then further distilled water, equal in volume to that of the dimethylformamide used, is added and the pH of the mixture raised to 6À5 to 7À0 with 10% sodium hydroxide solution. The precipitated antibiotic is either filtered off or centrifuged and washed with 50% n-propyl alcohol and then acetone. Finally the amphotericin B is dried under vacuum.
GB1390671A 1971-05-08 1971-05-08 A method of isolating and chemically purifying amphotericin b Expired GB1298172A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1390671A GB1298172A (en) 1971-05-08 1971-05-08 A method of isolating and chemically purifying amphotericin b

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1390671A GB1298172A (en) 1971-05-08 1971-05-08 A method of isolating and chemically purifying amphotericin b

Publications (1)

Publication Number Publication Date
GB1298172A true GB1298172A (en) 1972-11-29

Family

ID=10031533

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1390671A Expired GB1298172A (en) 1971-05-08 1971-05-08 A method of isolating and chemically purifying amphotericin b

Country Status (1)

Country Link
GB (1) GB1298172A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177265A (en) * 1977-03-02 1979-12-04 E. R. Squibb & Sons, Inc. Process for the purification of amphotericin B and A solubilizing media useful in that process
US5116960A (en) * 1988-06-13 1992-05-26 Beecham Group P.L.C. Amphotericin b derivatives
CN112175029A (en) * 2019-07-01 2021-01-05 刘力 Antifungal macrocyclic polyene compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177265A (en) * 1977-03-02 1979-12-04 E. R. Squibb & Sons, Inc. Process for the purification of amphotericin B and A solubilizing media useful in that process
US5116960A (en) * 1988-06-13 1992-05-26 Beecham Group P.L.C. Amphotericin b derivatives
CN112175029A (en) * 2019-07-01 2021-01-05 刘力 Antifungal macrocyclic polyene compounds

Similar Documents

Publication Publication Date Title
US3197466A (en) Penicillin sulfoxides and process
US2461922A (en) Antibiotic extraction from solids of actinomyces griseus culture
CA2092330C (en) Novel alkylenediammonium diclavulanate derivatives, a process for the preparation thereof as well as the use thereof
GB2145408A (en) Improvements in or relating to preparing sodium cefuroxime
GB1298172A (en) A method of isolating and chemically purifying amphotericin b
US4014994A (en) Process for the recovery and purification of partricin
Lucas et al. Oxidation of alginic acid by periodic acid
US2847471A (en) Method for purifying tetracycline
US2481763A (en) Technique for isolating subtilin
US2756226A (en) Acid-stable penicillins
US3634417A (en) Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
US2417584A (en) Method of producing antibacterial agent
DE1210861B (en) Process for the preparation of 7-aminocephalosporaneane derivatives
US3634416A (en) Purification of 7alpha-aminoarylacetamido delta**3-4-carboxy-cephalosporins
US3734828A (en) Process for the separation and purification of riboflavinyl glycosides
US3236841A (en) 7-acylaminocephalosporanic acids
US4490470A (en) Process for the separation and purification of dextranase
US3637654A (en) Purification of erythromycin thiocyanate
US2978447A (en) Preparation of p-aminobenzyl penicillin and derivatives thereof
SU522807A3 (en) The method of isolation of rifamycin
US4031085A (en) Preparation of 3-hydroxymethyl-7β-aminoadipoyl-7α-methoxy-3-cephem-4-carboxylic acid
US3847903A (en) Method for extracting and isolating rifamycin o from fermentation broths of rifamycins
US3013074A (en) Tetracycline purification process
US3349127A (en) Method of tetracycline isolation from fermented media
EP0081831A2 (en) Process for purifying elastase

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee